MOUNTAIN VIEW, Calif., May 10 /PRNewswire-FirstCall/ -- Pharsight Corporation , a leading provider of software and strategic services for optimizing clinical drug development, announced today that Mark Hovde, senior vice president of marketing, will present to members of the pharmaceutical and biotechnology industries attending the PharmaDiscovery 2006 Conference, "Follow the Science to PharmaDiscovery," to be held on May 10-12 at the Bethesda North Marriott Hotel and Conference Center, North Bethesda, Maryland. More information on the conference is available at http://www.pharmadiscoveryevent.com/.
Mr. Hovde's presentation, on May 12 at 1:30 PM eastern time, entitled "Simulations That Can Add Incremental Value," will provide an overview of the value of modeling and simulation in drug development, including the vision for increased use of modeling and simulation promulgated by the FDA in the Critical Path document, "Innovation or Stagnation." The presentation will also cover the business benefits of modeling and simulation, areas where it can have the most impact, and new technologies that can increase the power of modeling and simulation to influence decision-making in the drug development process.
About Pharsight Corporation
Pharsight Corporation develops and markets integrated products and services that enable pharmaceutical and biotechnology companies to achieve significant and enduring improvements in the development and use of therapeutic products. The company's goal is to help customers reduce the time, cost and risk of drug development, as well as optimize the post-approval marketing and use of pharmaceutical products.
Pharsight's approach enhances the fundamental element of drug development success: strong decision-making. By adopting the Pharsight approach, customers acquire a new decision-making process with the potential to systematically improve every level and phase of their business and scientific processes. Pharsight Corporation is headquartered in Mountain View, California. Information about Pharsight is available at http://www.pharsight.com.
Registered Trademarks and Trademarks
Pharsight(R) is a registered trademark of Pharsight Corporation.
Pharsight CorporationCONTACT: investors, Douglas Sherk, or Jennifer Beugelmans, both at+1-415-896-6820, or media, Steve DiMattia, +1-646-277-8706, all of EVCGroup for Pharsight Corporation
